Persistent hypercoagulability and acute limb ischemia post COVID-19

Research output: Contribution to journalArticlepeer-review

Abstract

Research indicates that COVID-19 induces endotheliitis, hypercoagulation, and hypofibrinolysis owing to virus-induced endothelial dysfunction. We present a case of a 34-year-old man with acute limb ischemia 4 days after COVID-19 diagnosis. Arterial duplex ultrasound examination revealed acute thrombosis of the popliteal artery and systemic anticoagulation was started. Despite multiple successful embolectomies and aggressive anticoagulant therapy, rethrombosis occurred, requiring bypass surgery approximately 1 year later. This case highlights the prolonged hypercoagulability post COVID-19 infection and the need for ongoing monitoring and tailored thromboprophylaxis to manage complications, especially with the evolving understanding of COVID-19-related hypercoagulability.

Original languageEnglish (US)
Article number101953
JournalJournal of Vascular Surgery Cases, Innovations and Techniques
Volume11
Issue number6
DOIs
StatePublished - Dec 2025

Keywords

  • Case report
  • COVID-19
  • Hypercoagulability
  • Thrombosis

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Persistent hypercoagulability and acute limb ischemia post COVID-19'. Together they form a unique fingerprint.

Cite this